Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia

Annals of Hematology

Volumn 81, Issue SUPPL. 2, 2002, Pages

  Schetelig, J ^a   Thiede, C ^a   Bornhauser M ^a   Schwerdtfeger, R ^a   Kiehl, M ^a   Beyer, J ^a   Kroger N ^a   Hensel, M ^a   Scheffold, C ^a   Ho, A D ^a   Kienast, J ^a   Neubauer, A ^a   Zander, A R ^a   Fauser, A A ^a   Ehninger, G ^a   Siegert, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOABLATIVE AGENT; THYMOCYTE ANTIBODY;

ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

BUSULFAN; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; RECURRENCE; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; VIDARABINE;

EID: 0036993015     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. O'Brien S, Kantarjian H, Beran M, et al: Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood 82:1695-1700, 1993
2. Zinzani PL, Bendandi M, Magagnoli M, et al: Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia. Haematologica 85:1135-1139, 2000
3. Bredeson CN, Sobocinski KA, Giralt S, et al: Salvage therapy for CLL: HLA-identical sibling transplantation vs. non-transplant therapies: an International Bone Marrow Transplant Registry and MD Anderson Cancer Center Study. Blood, 2001, pp 482
4. Michallet M, Archimbaud E, Bandini G, et al: HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med 124:311-315, 1996
5. Slavin S, Nagler A, Naparstek E, et al: Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91:756-763, 1998
6. Pavletic ZS, Arrowsmith ER, Bierman PJ, et al: Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia. Bone Marrow Transplant 25:717-722, 2000